DK0552205T3 - Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende dette - Google Patents
Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende detteInfo
- Publication number
- DK0552205T3 DK0552205T3 DK91917473T DK91917473T DK0552205T3 DK 0552205 T3 DK0552205 T3 DK 0552205T3 DK 91917473 T DK91917473 T DK 91917473T DK 91917473 T DK91917473 T DK 91917473T DK 0552205 T3 DK0552205 T3 DK 0552205T3
- Authority
- DK
- Denmark
- Prior art keywords
- medical use
- new medical
- pct
- pharmaceutical composition
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909022250A GB9022250D0 (en) | 1990-10-12 | 1990-10-12 | Medicaments |
| PCT/GB1991/001768 WO1992006688A1 (en) | 1990-10-12 | 1991-10-11 | New medical use for a certain indole derivative and pharmaceutical composition containing it |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0552205T3 true DK0552205T3 (da) | 1999-04-19 |
Family
ID=10683660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91917473T DK0552205T3 (da) | 1990-10-12 | 1991-10-11 | Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende dette |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5376672A (es) |
| EP (1) | EP0552205B1 (es) |
| JP (1) | JP3159263B2 (es) |
| KR (1) | KR0178762B1 (es) |
| AT (1) | ATE168006T1 (es) |
| AU (1) | AU660153B2 (es) |
| CA (1) | CA2093527A1 (es) |
| DE (1) | DE69129750T2 (es) |
| DK (1) | DK0552205T3 (es) |
| ES (1) | ES2118090T3 (es) |
| GB (1) | GB9022250D0 (es) |
| IE (1) | IE913580A1 (es) |
| IL (1) | IL99715A (es) |
| TW (1) | TW212756B (es) |
| WO (1) | WO1992006688A1 (es) |
| ZA (1) | ZA918117B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1598077B1 (en) * | 1993-12-28 | 2009-11-04 | Allergan, Inc. | Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle |
| EP2301562B1 (en) * | 1994-12-12 | 2013-04-17 | Omeros Corporation | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
| US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
| EP1765300A2 (en) * | 2004-06-10 | 2007-03-28 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| JP2010522135A (ja) | 2006-10-09 | 2010-07-01 | チャールストン ラボラトリーズ，インコーポレイテッド | 医薬組成物 |
| JP5714910B2 (ja) | 2008-01-09 | 2015-05-07 | チャールストン ラボラトリーズ，インコーポレイテッド | 薬学的組成物 |
| US8304179B2 (en) * | 2009-05-11 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for manufacturing a semiconductor device using a modified photosensitive layer |
| US20100287502A1 (en) * | 2009-05-11 | 2010-11-11 | Olympus Imaging Corp. | Image search device and image search method |
| CA2767576C (en) | 2009-07-08 | 2020-03-10 | Charleston Laboratories Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
| US10179109B2 (en) | 2016-03-04 | 2019-01-15 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
| GR79215B (es) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
| GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
-
1991
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-11 EP EP91917473A patent/EP0552205B1/en not_active Expired - Lifetime
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en active IP Right Grant
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active IP Right Cessation
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE168006T1 (de) | 1998-07-15 |
| CA2093527A1 (en) | 1992-04-13 |
| WO1992006688A1 (en) | 1992-04-30 |
| IL99715A0 (en) | 1992-08-18 |
| ZA918117B (en) | 1992-08-26 |
| AU8642291A (en) | 1992-05-20 |
| GB9022250D0 (en) | 1990-11-28 |
| TW212756B (es) | 1993-09-11 |
| US5376672A (en) | 1994-12-27 |
| KR0178762B1 (ko) | 1999-03-20 |
| IE913580A1 (en) | 1992-04-22 |
| JPH06501935A (ja) | 1994-03-03 |
| JP3159263B2 (ja) | 2001-04-23 |
| EP0552205A1 (en) | 1993-07-28 |
| EP0552205B1 (en) | 1998-07-08 |
| DE69129750D1 (de) | 1998-08-13 |
| IL99715A (en) | 1996-01-19 |
| DE69129750T2 (de) | 1998-11-12 |
| ES2118090T3 (es) | 1998-09-16 |
| AU660153B2 (en) | 1995-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0706378T3 (da) | Ny farmaceutisk formulering. | |
| IT1274879B (it) | Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo. | |
| TR199902253T2 (xx) | �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�. | |
| MY112915A (en) | Multiple unit tableted dosage form 1 | |
| CO4340681A1 (es) | Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero | |
| IL99676A0 (en) | Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines,and compositions and methods of use thereof | |
| CY1118924T1 (el) | Μεθοδος για θεραπεια της πρωτοπαθους αϋπνιας | |
| DK0678026T3 (da) | Anvendelse af carbamazepin og oxcarbazepin ved fremstilling af lægemidler til behandling af Parkinsons sygdom og parkinsonisme-syndromer | |
| DK0552205T3 (da) | Ny medicinsk anvendelse af et vist indolderivat og farmaceutisk præparat indeholdende dette | |
| DE69226649D1 (de) | Analoge des menschlichen Interleukin-8. | |
| DK0775143T3 (da) | 3-substituerede 3H-2,3-benzodiazepinderivater, deres fremstilling og anvendelse som lægdemidler | |
| HK1002658A1 (en) | Imidazopyridine-azolidinones their preparation and pharmaceutical use | |
| NO950177D0 (no) | Farmakologisk aktive erivater | |
| HUT77175A (hu) | Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények | |
| SE9404438D0 (sv) | New process | |
| SE9500897D0 (sv) | The pharmacological use of certain cystine derivatives |